Skip to main content

Table 2 Characteristics of the study population at baseline (intention-to-treat population)

From: Haem iron versus ferrous iron salts to treat iron deficiency anaemia in Gambian children: protocol for randomised controlled trial {1}

Baseline variable

Haem iron

Ferrous sulphate

n, as randomised

n

n

Age, months

Sex (male/female)

Number of live children born to the mother

Serum iron, μmol/L

Serum ferritin, μg/L

Serum soluble transferrin receptor, mg/L

Serum sTfR/log10(ferritin) index

Serum transferrin, g/L

UIBC, μmol/L

TSAT, %

Haemoglobin, g/dL

MCV, fL

MCH, pg

MCHC, g/dL

Reticulocyte count, × 109/L

Reticulocyte count

Immature reticulocyte fraction

Reticulocyte haemoglobin, pg

Serum hepcidin, μg/L

Serum erythropoietin, IU/L

Serum α1-acid glycoprotein, g/L

Serum erythroferrone, μg/L

Below or equal to LOQ (≤ 0.16 μg/L)

Serum C-reactive protein

Below or equal to LOQ (≤ 0.60 mg/L)

Height-for-age z-score, SD

Weight-for-age z-score, SD

Weight-for-height z-score, SD

  1. Values indicate n, mean (SD); n, geometric mean (geometric SD); n (%), prevalence; n, median (25 and 75% percentiles)
  2. LOQ limit of quantification, MCH mean corpuscular haemoglobin, MCHC mean corpuscular haemoglobin concentration, MCV mean corpuscular volume, sTfR soluble transferrin receptor, TSAT transferrin saturation, UIBC unsaturated iron-binding capacity